Director, Thought Leader Liaison - Sjögren’s Disease
Amgen
Summary
Sjögren’s disease is a chronic autoimmune condition with significant unmet need and no approved disease-modifying therapies. As Director, Thought Leader Liaison – Sjögren’s Disease, you will build and lead the national TLL team for one of Amgen’s highest-priority launches in Rare Disease. This is an opportunity to help shape how the market understands and engages with a complex disease, build trusted relationships with leading and emerging experts, and bring field insights into launch strategy and execution. You will work across U.S. Marketing, Medical Affairs, Field Medical, Sales, Market Access, and other partners to prepare for launch and support sustained adoption. The role is field-based, customer-facing, and accountable for developing a high-performing team and executing engagement with integrity and in full compliance with applicable requirements.
Job description
Key Responsibilities
- Set the TLL strategy and annual operating plan for Sjögren’s disease, aligned with brand strategy, launch priorities, and measurable objectives.
- Hire, lead, coach, and develop a high-performing national TLL team; establish clear goals, accountability, and development plans.
- Build a thoughtful engagement approach for leading and emerging experts across relevant specialties, using a strong understanding of the disease, treatment landscape, and customer needs.
- Partner with Marketing to develop speaker strategy and peer-to-peer programs and identify appropriate opportunities with relevant professional societies and congresses.
- Translate field insights, customer feedback, market research, and competitive intelligence into clear recommendations for brand strategy, launch planning, and customer experience.
- Work with cross-functional partners—including Marketing, Medical Affairs, Field Medical, Sales, Market Access, Patient Access, R&D, Advocacy, and Commercial Operations—to coordinate launch readiness and execution.
- Oversee TLL budgets, resource allocation, agency partners, and program performance; recommend adjustments based on business priorities and results.
- Ensure all team activities and external engagements meet Amgen’s standards and applicable commercial, regulatory, legal, and compliance requirements.
- Model Amgen Values and foster a culture of collaboration, inclusion, innovation, and accountability across the team and launch organization.
Requirements
- Doctorate degree and 4 years of marketing experience; OR
- Master's degree and 8 years of marketing/commercial experience; OR
- Bachelor's degree and 10 years of marketing/commercial experience.
- MBA preferred.
- Demonstrated success leading pharmaceutical or biotechnology product launches.
- Experience launching first-in-class therapies building markets in areas of high unmet need preferred.
- Demonstrated success leading through ambiguity and rapidly evolving competitive landscapes.
- Experience building commercial organizations and leading teams through pre-launch and launch preferred.
- Significant US marketing experience with integrated commercial strategy development.
- Experience hiring, coaching, and developing high-performing teams.
- Strong cross-functional leadership and executive communication skills.
- Experience in autoimmune disease, immunology, rheumatology, or rare disease preferred.
- Experience partnering with Medical Affairs, Market Access, Sales, and Global Marketing.
- Strong strategic thinking with the ability to translate insights into impactful commercial plans.
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Spending Accounts
- Annual Bonus
- Stock-Based Long-Term Incentives
- Paid Time Off
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.